Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$174K Sell
1,100
-34,300
-97% -$5.32M 0.01% 113
2026
Q1
$5.32M Hold
35,400
0.41% 75
2025
Q4
$5.71M Buy
35,400
+34,300
+3,118% +$6.25M 0.39% 68
2025
Q3
$216K Hold
1,100
0.02% 99
2025
Q2
$213K Hold
1,100
0.02% 99
2025
Q1
$129K Hold
1,100
0.01% 115
2024
Q4
$152K Hold
1,100
0.01% 111
2024
Q3
$130K Sell
1,100
-69,000
-98% -$5.86M 0.01% 115
2024
Q2
$6.03M Buy
+70,100
New +$5.87M 0.49% 69

Other funds holding VST

Payden & Rygel's VST Position: Q2 2026 in Review

Payden & Rygel reduced its Vistra (VST) stake by 97% in Q2 2026, selling an estimated $5.32M and leaving 1,100 shares worth $174K. The position accounts for 0.01% of the portfolio, ranked #113.

Payden & Rygel first reported a position in VST in Q2 2024 and has held it in 9 quarters since. The position peaked at $6.03M in Q2 2024. 1,406 funds tracked by Wall St. Rank hold VST as of Q2 2026.

  • Payden & Rygel held 1,100 shares of Vistra worth $174K as of Q2 2026.
  • Payden & Rygel sold 34,300 Vistra shares in Q2 2026, an estimated $5.32M.
  • Vistra made up 0.01% of Payden & Rygel's portfolio in Q2 2026, its #113 holding.
  • Payden & Rygel first reported a position in Vistra in Q2 2024 and has held it in 9 quarters since.
  • Payden & Rygel's Vistra position peaked at $6.03M in Q2 2024.
  • 1,406 funds tracked by Wall St. Rank held Vistra as of Q2 2026.

Based on Payden & Rygel's 13F filing for Q2 2026, filed 31 Jul 2026.